NL-OMON53159招募中不适用
Somatostatin receptor expression and occupancy during lanreotide therapy - Somatostatin receptor occupancy
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- >=18 years old
- •- Histologically confirmed low and intermediate grade NET
- •- Metastatic or unresectable disease
- •- Measurable disease on [68Ga]-DOTATATE PET-scan
- •- WHO performance status less than 2
- •- Life expectancy more than 3 months
- •- Long-acting lanreotide treatment for at least 4 months
排除标准
- •- Pregnant or breast-feeding
- •- Claustrophobic
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the expression of somatostatin receptors in DOTATOC-68Ga PET scans in patients followed for metastatic breast cancerBreast CancerCTIS2023-504458-36-02Centre Hospitalier Universitaire Grenoble Alpes25
进行中（未招募）
不适用
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI TractNeuroendocrine CarcinomaNCT04069299H. Lee Moffitt Cancer Center and Research Institute30
进行中（未招募）
1 期
Assessment of PET for detection of infectious myocarditisEUCTR2019-002716-43-FRCHRU DE NANCY33
已完成
不适用
Somatostatin Receptor Imaging in NPC, EBV Related CancersNasopharyngeal CancerEpstein-Barr Virus Related CarcinomaNCT05581550National Cancer Centre, Singapore15
招募中
3 期
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast CancerBreast Cancer MetastaticNCT06611891University Hospital, Grenoble25